{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T18:56:54Z","timestamp":1722711414494},"reference-count":190,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T00:00:00Z","timestamp":1506124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,23]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The development of improved cancer therapies is frequently cited as an urgent unmet medical need. Here we describe how genetic interactions are being therapeutically exploited to identify novel targeted treatments for cancer. We discuss the current methodologies that use \u2018omics data to identify genetic interactions, in particular focusing on synthetic sickness lethality (SSL) and synthetic dosage lethality (SDL). We describe the experimental and computational approaches undertaken both in humans and model organisms to identify these interactions. Finally we discuss some of the identified targets with licensed drugs, inhibitors in clinical trials or with compounds under development.<\/jats:p>","DOI":"10.1515\/jib-2017-0027","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T10:01:08Z","timestamp":1506160868000},"source":"Crossref","is-referenced-by-count":2,"title":["Computational Approaches to Identify Genetic Interactions for Cancer Therapeutics"],"prefix":"10.1515","volume":"14","author":[{"given":"Graeme","family":"Benstead-Hume","sequence":"first","affiliation":[{"name":"School of Life Sciences, University of Sussex, Brighton, UK"}]},{"given":"Sarah K.","family":"Wooller","sequence":"additional","affiliation":[{"name":"School of Life Sciences, University of Sussex, Brighton, UK"}]},{"given":"Frances M.G.","family":"Pearl","sequence":"additional","affiliation":[{"name":"School of Life Sciences, University of Sussex, Brighton, UK"}]}],"member":"374","reference":[{"key":"ref611","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.maturitas.2015.01.015","article-title":"PARP inhibitors: a new era of targeted therapy","volume":"81","year":"2015","journal-title":"Maturitas"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"ref1821","first-page":"D635","article-title":"Ensembl 2017","volume":"45","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref1121","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/cib.2.1.7298","article-title":"The functional relationships underlying a synthetic genetic network","volume":"2","year":"2009","journal-title":"Commun Integr Biol"},{"key":"ref1921","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nature05649","article-title":"Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map","volume":"446","year":"2007","journal-title":"Nature"},{"key":"ref1891","doi-asserted-by":"crossref","first-page":"D1011","DOI":"10.1093\/nar\/gkv1108","article-title":"SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets","volume":"44","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/cib.7501","article-title":"Exploring the conservation of synthetic lethal genetic interaction networks","volume":"2","year":"2009","journal-title":"Commun Integr Biol"},{"key":"ref1721","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1158\/1078-0432.CCR-14-2180","article-title":"RAS synthetic lethal screens revisited: still seeking the elusive prize?","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ccr.2010.05.025","article-title":"A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma","volume":"18","year":"2010","journal-title":"Cancer Cell"},{"key":"ref1221","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymeth.2006.07.033","article-title":"dSLAM analysis of genome-wide genetic interactions in Saccharomyces cerevisiae","volume":"41","year":"2007","journal-title":"Methods"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.coph.2013.06.004","article-title":"Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology","volume":"13","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"ref1401","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/cib.7501","article-title":"Exploring the conservation of synthetic lethal genetic interaction networks","volume":"2","year":"2009","journal-title":"Commun Integr Biol"},{"key":"ref1651","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature11331","article-title":"Passenger deletions generate therapeutic vulnerabilities in cancer","volume":"488","year":"2012","journal-title":"Nature"},{"key":"ref881","first-page":"l1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","year":"2013","journal-title":"Sci Signal"},{"key":"ref1581","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.maturitas.2015.01.015","article-title":"PARP inhibitors: a new era of targeted therapy","volume":"81","year":"2015","journal-title":"Maturitas"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrc1691","article-title":"The concept of synthetic lethality in the context of anticancer therapy","volume":"5","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","article-title":"The determination and interpretation of the therapeutic index in drug development","volume":"11","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"D824","DOI":"10.1093\/nar\/gkn832","article-title":"MoKCa database\u2014mutations of kinases in cancer","volume":"37","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref1491","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","year":"2015","journal-title":"Contemp Oncol"},{"key":"ref991","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","article-title":"On the receiving end\u2014patient perception of the side-effects of cancer chemotherapy","volume":"19","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1755-8794-6-30","article-title":"Identification of potential synthetic lethal genes to p53 using a computational biology approach","volume":"6","year":"2013","journal-title":"BMC Med Genomics"},{"key":"ref1841","first-page":"bar026","article-title":"International Cancer Genome Consortium Data Portal\u2014a one-stop shop for cancer genomics data","volume":"2011","year":"2011","journal-title":"Database"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature02371","article-title":"A large-scale RNAi screen in human cells identifies new components of the p53 pathway","volume":"428","year":"2004","journal-title":"Nature"},{"key":"ref861","first-page":"D695","article-title":"NetworKIN: a resource for exploring cellular phosphorylation networks","volume":"36","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.cell.2014.07.027","article-title":"Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality","volume":"158","year":"2014","journal-title":"Cell"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"D746","DOI":"10.1093\/nar\/gkv1045","article-title":"Expression Atlas update\u2014an integrated database of gene and protein expression in humans, animals and plants","volume":"44","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref931","first-page":"353","article-title":"A global genetic interaction network maps a wiring diagram of cellular function","year":"2016","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","article-title":"On the receiving end\u2014patient perception of the side-effects of cancer chemotherapy","volume":"19","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"ref1741","doi-asserted-by":"crossref","first-page":"e0149099","DOI":"10.1371\/journal.pone.0149099","article-title":"CDK1 is a synthetic lethal target for KRAS mutant tumours","volume":"11","year":"2016","journal-title":"PLoS One"},{"key":"ref1391","doi-asserted-by":"crossref","first-page":"e1004506","DOI":"10.1371\/journal.pcbi.1004506","article-title":"Connectivity homology enables inter-species network models of synthetic lethality","volume":"11","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrc3891","article-title":"Therapeutic opportunities within the DNA damage response","volume":"15","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"ref1361","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1755-8794-6-30","article-title":"Identification of potential synthetic lethal genes to p53 using a computational biology approach","volume":"6","year":"2013","journal-title":"BMC Med Genomics"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrd2355","article-title":"Utilizing RNA interference to enhance cancer drug discovery","volume":"6","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","year":"2000","journal-title":"Nat Genet"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13062-015-0086-1","article-title":"Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer","volume":"10","year":"2015","journal-title":"Biol Direct"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nature05649","article-title":"Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map","volume":"446","year":"2007","journal-title":"Nature"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00039-9","article-title":"Smart drugs: tyrosine kinase inhibitors in cancer therapy","volume":"1","year":"2002","journal-title":"Cancer Cell"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2009.03.017","article-title":"Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells","volume":"137","year":"2009","journal-title":"Cell"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-repair defects and olaparib in metastatic prostate cancer","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2013.09.057","article-title":"Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors","volume":"155","year":"2013","journal-title":"Cell"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/jbiol58","article-title":"A global analysis of genetic interactions in Caenorhabditis elegans","volume":"6","year":"2007","journal-title":"J Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"12217","DOI":"10.1073\/pnas.1508573112","article-title":"Synthetic dosage lethality in the human metabolic network is highly predictive of tumor growth and cancer patient survival","volume":"112","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref1351","first-page":"7","article-title":"SSLPred: predicting synthetic sickness lethality","year":"2012","journal-title":"Pac Symp Biocomput"},{"key":"ref401","first-page":"71","article-title":"In silico prediction of synthetic lethality by meta-analysis of genetic interactions, functions, and pathways in yeast and human cancer","volume":"13","year":"2014","journal-title":"Cancer Inform"},{"key":"ref1911","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/420333","article-title":"Progress and prospects in evolutionary biology: the Drosophila model. Jeffrey R. Powell","volume":"73","year":"1998","journal-title":"Q Rev Biol"},{"key":"ref1731","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.aam7622","article-title":"Drugging RAS: know the enemy","volume":"355","year":"2017","journal-title":"Science"},{"key":"ref521","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","year":"2015","journal-title":"Contemp Oncol"},{"key":"ref1861","doi-asserted-by":"crossref","first-page":"10.11.1","DOI":"10.1002\/cphg.21","article-title":"COSMIC: high-resolution cancer genetics using the catalogue of somatic mutations in cancer","volume":"91","year":"2016","journal-title":"Curr Protoc Hum Genet"},{"key":"ref1671","doi-asserted-by":"crossref","first-page":"13837","DOI":"10.1038\/ncomms13837","article-title":"ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A","volume":"7","year":"2016","journal-title":"Nat Commun"},{"key":"ref1641","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","article-title":"Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers","volume":"21","year":"2015","journal-title":"Nat Med"},{"key":"ref1571","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ygyno.2014.02.039","article-title":"PARP inhibitors in ovarian cancer: current status and future promise","volume":"133","year":"2014","journal-title":"Gynecol Oncol"},{"key":"ref1141","doi-asserted-by":"crossref","first-page":"12217","DOI":"10.1073\/pnas.1508573112","article-title":"Synthetic dosage lethality in the human metabolic network is highly predictive of tumor growth and cancer patient survival","volume":"112","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1126\/science.1065810","article-title":"Systematic genetic analysis with ordered arrays of yeast deletion mutants","volume":"294","year":"2001","journal-title":"Science"},{"key":"ref1381","doi-asserted-by":"crossref","first-page":"1541002","DOI":"10.1142\/S0219720015410024","article-title":"Predicting essential genes and synthetic lethality via influence propagation in signaling pathways of cancer cell fates","volume":"13","year":"2015","journal-title":"J Bioinform Comput Biol"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40265-017-0716-2","article-title":"Rucaparib: first global approval","volume":"77","year":"2017","journal-title":"Drugs"},{"key":"ref1211","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1126\/science.1065810","article-title":"Systematic genetic analysis with ordered arrays of yeast deletion mutants","volume":"294","year":"2001","journal-title":"Science"},{"key":"ref1301","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2009.05.006","article-title":"A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene","volume":"137","year":"2009","journal-title":"Cell"},{"key":"ref1371","first-page":"71","article-title":"In silico prediction of synthetic lethality by meta-analysis of genetic interactions, functions, and pathways in yeast and human cancer","volume":"13","year":"2014","journal-title":"Cancer Inform"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"D535","DOI":"10.1093\/nar\/gkj109","article-title":"BioGRID: a general repository for interaction datasets","volume":"34","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"e60847","DOI":"10.1371\/journal.pone.0060847","article-title":"Systematic analysis of experimental phenotype data reveals gene functions","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.1091317","article-title":"Global mapping of the yeast genetic interaction network","volume":"303","year":"2004","journal-title":"Science"},{"key":"ref1231","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0076-6879(10)70009-4","article-title":"Quantitative genetic interaction mapping using the E-MAP approach","volume":"470","year":"2010","journal-title":"Methods Enzymol"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"ref1621","first-page":"43","article-title":"A pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a BRCA mutation","volume":"27","year":"2016","journal-title":"Ann Oncol"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.aam7622","article-title":"Drugging RAS: know the enemy","volume":"355","year":"2017","journal-title":"Science"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13059-015-0612-6","article-title":"Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations","volume":"16","year":"2015","journal-title":"Genome Biol"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"ref1471","volume-title":"Biological data mining in protein interaction networks","year":"2009"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1634\/theoncologist.2008-0019","article-title":"Gefitinib in advanced non-small cell lung cancer: does it deserve a second chance?","volume":"13","year":"2008","journal-title":"Oncologist"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","year":"2009","journal-title":"Nature"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2009.05.006","article-title":"A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene","volume":"137","year":"2009","journal-title":"Cell"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1158\/1078-0432.CCR-14-2180","article-title":"RAS synthetic lethal screens revisited: still seeking the elusive prize?","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.18632\/oncotarget.1926","article-title":"Targeting human apurinic\/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy","volume":"5","year":"2014","journal-title":"Oncotarget"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"ref1081","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1634\/theoncologist.2008-0019","article-title":"Gefitinib in advanced non-small cell lung cancer: does it deserve a second chance?","volume":"13","year":"2008","journal-title":"Oncologist"},{"key":"ref1261","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrd2355","article-title":"Utilizing RNA interference to enhance cancer drug discovery","volume":"6","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"A44","DOI":"10.1158\/1557-3265.PMCCAVULN16-A44","article-title":"Abstract A44: a landscape of pharmacogenomic interactions in cancer","volume":"23","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJMra1407390","article-title":"Applying synthetic lethality for the selective targeting of cancer","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1158\/1078-0432.CCR-15-0479","article-title":"Molecular pathways: targeting ATR in cancer therapy","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref1661","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.18632\/oncotarget.1926","article-title":"Targeting human apurinic\/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy","volume":"5","year":"2014","journal-title":"Oncotarget"},{"key":"ref1781","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"ref1281","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature02371","article-title":"A large-scale RNAi screen in human cells identifies new components of the p53 pathway","volume":"428","year":"2004","journal-title":"Nature"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00039-9","article-title":"Smart drugs: tyrosine kinase inhibitors in cancer therapy","volume":"1","year":"2002","journal-title":"Cancer Cell"},{"key":"ref1871","doi-asserted-by":"crossref","first-page":"D824","DOI":"10.1093\/nar\/gkn832","article-title":"MoKCa database\u2014mutations of kinases in cancer","volume":"37","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref1411","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1752-0509-3-116","article-title":"Human synthetic lethal inference as potential anti-cancer target gene detection","volume":"3","year":"2009","journal-title":"BMC Syst Biol"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/gb-2012-13-7-r57","article-title":"Conserved rules govern genetic interaction degree across species","volume":"13","year":"2012","journal-title":"Genome Biol"},{"key":"ref1501","first-page":"202","article-title":"CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer","year":"2015","journal-title":"Lect Notes Comput Sci"},{"key":"ref1791","doi-asserted-by":"crossref","first-page":"D82","DOI":"10.1093\/nar\/gku1163","article-title":"COXPRESdb in 2015: coexpression database for animal species by DNA-microarray and RNAseq-based expression data with multiple quality assessment systems","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.celrep.2013.11.033","article-title":"Recessive cancer genes engage in negative genetic interactions with their functional paralogs","volume":"5","year":"2013","journal-title":"Cell Rep"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ygyno.2014.02.039","article-title":"PARP inhibitors in ovarian cancer: current status and future promise","volume":"133","year":"2014","journal-title":"Gynecol Oncol"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: weaving a tumorigenic web","volume":"11","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref1681","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1158\/1078-0432.CCR-15-0479","article-title":"Molecular pathways: targeting ATR in cancer therapy","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref1771","doi-asserted-by":"crossref","first-page":"D746","DOI":"10.1093\/nar\/gkv1045","article-title":"Expression Atlas update\u2014an integrated database of gene and protein expression in humans, animals and plants","volume":"44","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1471-2105-11-343","article-title":"A semi-supervised learning approach to predict synthetic genetic interactions by combining functional and topological properties of functional gene network","volume":"11","year":"2010","journal-title":"BMC Bioinform"},{"key":"ref1831","first-page":"D695","article-title":"NetworKIN: a resource for exploring cellular phosphorylation networks","volume":"36","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref1901","first-page":"353","article-title":"A global genetic interaction network maps a wiring diagram of cellular function","year":"2016","journal-title":"Science"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"D995","DOI":"10.1093\/nar\/gkw1072","article-title":"Pharos: collating protein information to shed light on the druggable genome","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"ref1131","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.278.5340.1064","article-title":"Integrating genetic approaches into the discovery of anticancer drugs","volume":"278","year":"1997","journal-title":"Science"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","article-title":"Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers","volume":"21","year":"2015","journal-title":"Nat Med"},{"key":"ref1461","doi-asserted-by":"crossref","first-page":"e60847","DOI":"10.1371\/journal.pone.0060847","article-title":"Systematic analysis of experimental phenotype data reveals gene functions","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/msb.2010.82","article-title":"Genetic interactions reveal the evolutionary trajectories of duplicate genes","volume":"6","year":"2010","journal-title":"Mol Syst Biol"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/ncomms3124","article-title":"Genome evolution predicts genetic interactions in protein complexes and reveals cancer drug targets","volume":"4","year":"2013","journal-title":"Nat Commun"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"15682","DOI":"10.1073\/pnas.0406614101","article-title":"Combining biological networks to predict genetic interactions","volume":"101","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"15682","DOI":"10.1073\/pnas.0406614101","article-title":"Combining biological networks to predict genetic interactions","volume":"101","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.278.5340.1064","article-title":"Integrating genetic approaches into the discovery of anticancer drugs","volume":"278","year":"1997","journal-title":"Science"},{"key":"ref1111","first-page":"7","article-title":"Clinical overview of MDM2\/X-targeted therapies","volume":"6","year":"2016","journal-title":"Front Oncol"},{"key":"ref1551","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","year":"2005","journal-title":"Nature"},{"key":"ref1601","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40265-017-0716-2","article-title":"Rucaparib: first global approval","volume":"77","year":"2017","journal-title":"Drugs"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.febslet.2010.11.024","article-title":"Synthetic lethality: general principles, utility and detection using genetic screens in human cells","volume":"585","year":"2011","journal-title":"FEBS Lett"},{"key":"ref851","first-page":"D635","article-title":"Ensembl 2017","volume":"45","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref971","article-title":"The hallmarks of cancer","volume":"100","year":"2000","journal-title":"Cell"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"D995","DOI":"10.1093\/nar\/gkw1072","article-title":"Pharos: collating protein information to shed light on the druggable genome","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2105-10-17","article-title":"Predicting genetic interactions with random walks on biological networks","volume":"10","year":"2009","journal-title":"BMC Bioinform"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.1123287","article-title":"Genome-wide prediction of C. elegans genetic interactions","volume":"311","year":"2006","journal-title":"Science"},{"key":"ref501","volume-title":"Biological data mining in protein interaction networks","year":"2009"},{"key":"ref1321","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.1123287","article-title":"Genome-wide prediction of C. elegans genetic interactions","volume":"311","year":"2006","journal-title":"Science"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/emboj.2008.61","article-title":"A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor","volume":"27","year":"2008","journal-title":"EMBO J"},{"key":"ref1101","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrd4288","article-title":"Drugging the p53 pathway: understanding the route to clinical efficacy","volume":"13","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"ref1331","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/1471-2105-9-426","article-title":"Mining protein networks for synthetic genetic interactions","volume":"9","year":"2008","journal-title":"BMC Bioinform"},{"key":"ref1711","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ccr.2010.05.025","article-title":"A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma","volume":"18","year":"2010","journal-title":"Cancer Cell"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"e0149099","DOI":"10.1371\/journal.pone.0149099","article-title":"CDK1 is a synthetic lethal target for KRAS mutant tumours","volume":"11","year":"2016","journal-title":"PLoS One"},{"key":"ref1431","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/gb-2012-13-7-r57","article-title":"Conserved rules govern genetic interaction degree across species","volume":"13","year":"2012","journal-title":"Genome Biol"},{"key":"ref1451","doi-asserted-by":"crossref","first-page":"e1000443","DOI":"10.1371\/journal.pcbi.1000443","article-title":"Semantic similarity in biomedical ontologies","volume":"5","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"e1000443","DOI":"10.1371\/journal.pcbi.1000443","article-title":"Semantic similarity in biomedical ontologies","volume":"5","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrd4288","article-title":"Drugging the p53 pathway: understanding the route to clinical efficacy","volume":"13","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"ref1691","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.coph.2013.06.004","article-title":"Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology","volume":"13","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"ref01","article-title":"The hallmarks of cancer","volume":"100","year":"2000","journal-title":"Cell"},{"key":"ref1531","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.cell.2014.07.027","article-title":"Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality","volume":"158","year":"2014","journal-title":"Cell"},{"key":"ref1291","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","year":"2009","journal-title":"Nature"},{"key":"ref1481","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1755-8794-4-34","article-title":"Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors","volume":"4","year":"2011","journal-title":"BMC Med Genomics"},{"key":"ref1801","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","year":"2000","journal-title":"Nat Genet"},{"key":"ref1931","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/jbiol58","article-title":"A global analysis of genetic interactions in Caenorhabditis elegans","volume":"6","year":"2007","journal-title":"J Biol"},{"key":"ref921","doi-asserted-by":"crossref","first-page":"D1011","DOI":"10.1093\/nar\/gkv1108","article-title":"SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets","volume":"44","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref1251","year":"2007","journal-title":"Meta-analysis of genomic and proteomic features to predict synthetic lethality of yeast and human cancer"},{"key":"ref1521","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13062-015-0086-1","article-title":"Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer","volume":"10","year":"2015","journal-title":"Biol Direct"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","year":"2011","journal-title":"Cell"},{"key":"ref1271","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2009.03.017","article-title":"Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells","volume":"137","year":"2009","journal-title":"Cell"},{"key":"ref1421","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/msb.2010.82","article-title":"Genetic interactions reveal the evolutionary trajectories of duplicate genes","volume":"6","year":"2010","journal-title":"Mol Syst Biol"},{"key":"ref1561","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/emboj.2008.61","article-title":"A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor","volume":"27","year":"2008","journal-title":"EMBO J"},{"key":"ref651","first-page":"43","article-title":"A pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a BRCA mutation","volume":"27","year":"2016","journal-title":"Ann Oncol"},{"key":"ref1541","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrc3891","article-title":"Therapeutic opportunities within the DNA damage response","volume":"15","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"ref1441","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/ncomms3124","article-title":"Genome evolution predicts genetic interactions in protein complexes and reveals cancer drug targets","volume":"4","year":"2013","journal-title":"Nat Commun"},{"key":"ref1591","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-repair defects and olaparib in metastatic prostate cancer","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"ref1701","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: weaving a tumorigenic web","volume":"11","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref1161","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.celrep.2013.11.033","article-title":"Recessive cancer genes engage in negative genetic interactions with their functional paralogs","volume":"5","year":"2013","journal-title":"Cell Rep"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1471-2105-11-343","article-title":"A semi-supervised learning approach to predict synthetic genetic interactions by combining functional and topological properties of functional gene network","volume":"11","year":"2010","journal-title":"BMC Bioinform"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1755-8794-4-34","article-title":"Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors","volume":"4","year":"2011","journal-title":"BMC Med Genomics"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","year":"2011","journal-title":"Cell"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrc1691","article-title":"The concept of synthetic lethality in the context of anticancer therapy","volume":"5","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref1511","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13059-015-0612-6","article-title":"Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations","volume":"16","year":"2015","journal-title":"Genome Biol"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"13837","DOI":"10.1038\/ncomms13837","article-title":"ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A","volume":"7","year":"2016","journal-title":"Nat Commun"},{"key":"ref381","first-page":"7","article-title":"SSLPred: predicting synthetic sickness lethality","year":"2012","journal-title":"Pac Symp Biocomput"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"10.11.1","DOI":"10.1002\/cphg.21","article-title":"COSMIC: high-resolution cancer genetics using the catalogue of somatic mutations in cancer","volume":"91","year":"2016","journal-title":"Curr Protoc Hum Genet"},{"key":"ref1181","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2105-10-17","article-title":"Predicting genetic interactions with random walks on biological networks","volume":"10","year":"2009","journal-title":"BMC Bioinform"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"e1004506","DOI":"10.1371\/journal.pcbi.1004506","article-title":"Connectivity homology enables inter-species network models of synthetic lethality","volume":"11","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"ref1151","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJMra1407390","article-title":"Applying synthetic lethality for the selective targeting of cancer","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature11331","article-title":"Passenger deletions generate therapeutic vulnerabilities in cancer","volume":"488","year":"2012","journal-title":"Nature"},{"key":"ref1851","first-page":"l1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","year":"2013","journal-title":"Sci Signal"},{"key":"ref1811","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"A44","DOI":"10.1158\/1557-3265.PMCCAVULN16-A44","article-title":"Abstract A44: a landscape of pharmacogenomic interactions in cancer","volume":"23","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref871","first-page":"bar026","article-title":"International Cancer Genome Consortium Data Portal\u2014a one-stop shop for cancer genomics data","volume":"2011","year":"2011","journal-title":"Database"},{"key":"ref1881","doi-asserted-by":"crossref","first-page":"D535","DOI":"10.1093\/nar\/gkj109","article-title":"BioGRID: a general repository for interaction datasets","volume":"34","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref281","year":"2007","journal-title":"Meta-analysis of genomic and proteomic features to predict synthetic lethality of yeast and human cancer"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"1541002","DOI":"10.1142\/S0219720015410024","article-title":"Predicting essential genes and synthetic lethality via influence propagation in signaling pathways of cancer cell fates","volume":"13","year":"2015","journal-title":"J Bioinform Comput Biol"},{"key":"ref1201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.febslet.2010.11.024","article-title":"Synthetic lethality: general principles, utility and detection using genetic screens in human cells","volume":"585","year":"2011","journal-title":"FEBS Lett"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymeth.2006.07.033","article-title":"dSLAM analysis of genome-wide genetic interactions in Saccharomyces cerevisiae","volume":"41","year":"2007","journal-title":"Methods"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0076-6879(10)70009-4","article-title":"Quantitative genetic interaction mapping using the E-MAP approach","volume":"470","year":"2010","journal-title":"Methods Enzymol"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng1258","article-title":"DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray","volume":"35","year":"2003","journal-title":"Nat Genet"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2012.02.059","article-title":"The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer","volume":"149","year":"2012","journal-title":"Cell"},{"key":"ref1171","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.1091317","article-title":"Global mapping of the yeast genetic interaction network","volume":"303","year":"2004","journal-title":"Science"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","year":"2005","journal-title":"Nature"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(05)67625-8","article-title":"Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"ref1241","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng1258","article-title":"DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray","volume":"35","year":"2003","journal-title":"Nat Genet"},{"key":"ref531","first-page":"202","article-title":"CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer","year":"2015","journal-title":"Lect Notes Comput Sci"},{"key":"ref141","first-page":"7","article-title":"Clinical overview of MDM2\/X-targeted therapies","volume":"6","year":"2016","journal-title":"Front Oncol"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/420333","article-title":"Progress and prospects in evolutionary biology: the Drosophila model. Jeffrey R. Powell","volume":"73","year":"1998","journal-title":"Q Rev Biol"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/cib.2.1.7298","article-title":"The functional relationships underlying a synthetic genetic network","volume":"2","year":"2009","journal-title":"Commun Integr Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","article-title":"The determination and interpretation of the therapeutic index in drug development","volume":"11","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"ref1761","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(05)67625-8","article-title":"Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"ref1751","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2012.02.059","article-title":"The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer","volume":"149","year":"2012","journal-title":"Cell"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/1471-2105-9-426","article-title":"Mining protein networks for synthetic genetic interactions","volume":"9","year":"2008","journal-title":"BMC Bioinform"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1752-0509-3-116","article-title":"Human synthetic lethal inference as potential anti-cancer target gene detection","volume":"3","year":"2009","journal-title":"BMC Syst Biol"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"D82","DOI":"10.1093\/nar\/gku1163","article-title":"COXPRESdb in 2015: coexpression database for animal species by DNA-microarray and RNAseq-based expression data with multiple quality assessment systems","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"ref1631","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2013.09.057","article-title":"Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors","volume":"155","year":"2013","journal-title":"Cell"}],"container-title":["Journal of Integrative Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/jib\/14\/3\/article-20170027.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jib-2017-0027\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T08:08:25Z","timestamp":1659514105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jib-2017-0027\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":190,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1515\/jib-2017-0027","relation":{},"ISSN":["1613-4516"],"issn-type":[{"value":"1613-4516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,23]]}}}